147 related articles for article (PubMed ID: 34400125)
1. Dihydroartemisinin regulates lipid droplet metabolism in hepatic stellate cells by inhibiting lncRNA-H19-induced AMPK signal.
Xia S; Wang Z; Chen L; Zhou Y; Li Y; Wang S; Chen A; Xu X; Shao J; Zhang Z; Tan S; Zhang F; Zheng S
Biochem Pharmacol; 2021 Oct; 192():114730. PubMed ID: 34400125
[TBL] [Abstract][Full Text] [Related]
2. HIF-1α-upregulated lncRNA-H19 regulates lipid droplet metabolism through the AMPKα pathway in hepatic stellate cells.
Wang Z; Yang X; Kai J; Wang F; Wang Z; Shao J; Tan S; Chen A; Zhang F; Wang S; Zhang Z; Zheng S
Life Sci; 2020 Aug; 255():117818. PubMed ID: 32445757
[TBL] [Abstract][Full Text] [Related]
3. LncRNA-H19 induces hepatic stellate cell activation via upregulating alcohol dehydrogenase III-mediated retinoic acid signals.
Wang ZM; Xia SW; Zhang T; Wang ZY; Yang X; Kai J; Cheng XD; Shao JJ; Tan SZ; Chen AP; Wang SJ; Zhang F; Zhang ZL; Zheng SZ
Int Immunopharmacol; 2020 Jul; 84():106470. PubMed ID: 32304991
[TBL] [Abstract][Full Text] [Related]
4. The blockade of lipophagy pathway is necessary for docosahexaenoic acid to regulate lipid droplet turnover in hepatic stellate cells.
Qiu S; Xu H; Lin Z; Liu F; Tan F
Biomed Pharmacother; 2019 Jan; 109():1841-1850. PubMed ID: 30551439
[TBL] [Abstract][Full Text] [Related]
5. Autophagy regulates turnover of lipid droplets via ROS-dependent Rab25 activation in hepatic stellate cell.
Zhang Z; Zhao S; Yao Z; Wang L; Shao J; Chen A; Zhang F; Zheng S
Redox Biol; 2017 Apr; 11():322-334. PubMed ID: 28038427
[TBL] [Abstract][Full Text] [Related]
6. Danhongqing formula alleviates cholestatic liver fibrosis by downregulating long non-coding RNA H19 derived from cholangiocytes and inhibiting hepatic stellate cell activation.
Li M; Zhou Y; Zhu H; Xu LM; Ping J
J Integr Med; 2024 Mar; 22(2):188-198. PubMed ID: 38472011
[TBL] [Abstract][Full Text] [Related]
7. Oroxylin A regulates the turnover of lipid droplet via downregulating adipose triglyceride lipase (ATGL) in hepatic stellate cells.
Zhang Z; Guo M; Shen M; Li Y; Tan S; Shao J; Zhang F; Chen A; Wang S; Zheng S
Life Sci; 2019 Dec; 238():116934. PubMed ID: 31610205
[TBL] [Abstract][Full Text] [Related]
8. Curcumin Recovers Intracellular Lipid Droplet Formation Through Increasing Perilipin 5 Gene Expression in Activated Hepatic Stellate Cells In Vitro.
Han XQ; Xu SQ; Lin JG
Curr Med Sci; 2019 Oct; 39(5):766-777. PubMed ID: 31612395
[TBL] [Abstract][Full Text] [Related]
9. DNMT1 controls LncRNA H19/ERK signal pathway in hepatic stellate cell activation and fibrosis.
Yang JJ; She Q; Yang Y; Tao H; Li J
Toxicol Lett; 2018 Oct; 295():325-334. PubMed ID: 30010033
[TBL] [Abstract][Full Text] [Related]
10. Perilipin 5 restores the formation of lipid droplets in activated hepatic stellate cells and inhibits their activation.
Lin J; Chen A
Lab Invest; 2016 Jul; 96(7):791-806. PubMed ID: 27135793
[TBL] [Abstract][Full Text] [Related]
11. Fibronectin Type III Domain-Containing 5 Attenuates Liver Fibrosis Via Inhibition of Hepatic Stellate Cell Activation.
Zhou B; Ling L; Zhang F; Liu TY; Zhou H; Qi XH; Chen Q; Li YH; Kang YM; Zhu GQ
Cell Physiol Biochem; 2018; 48(1):227-236. PubMed ID: 30007970
[TBL] [Abstract][Full Text] [Related]
12. Dihydroartemisinin counteracts fibrotic portal hypertension via farnesoid X receptor-dependent inhibition of hepatic stellate cell contraction.
Xu W; Lu C; Zhang F; Shao J; Yao S; Zheng S
FEBS J; 2017 Jan; 284(1):114-133. PubMed ID: 27896916
[TBL] [Abstract][Full Text] [Related]
13. Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells
Li Z; Ding Q; Ling LP; Wu Y; Meng DX; Li X; Zhang CQ
World J Gastroenterol; 2018 Feb; 24(7):819-832. PubMed ID: 29467552
[TBL] [Abstract][Full Text] [Related]
14. IGFBPrP1 accelerates autophagy and activation of hepatic stellate cells via mutual regulation between H19 and PI3K/AKT/mTOR pathway.
Huang TJ; Ren JJ; Zhang QQ; Kong YY; Zhang HY; Guo XH; Fan HQ; Liu LX
Biomed Pharmacother; 2019 Aug; 116():109034. PubMed ID: 31152924
[TBL] [Abstract][Full Text] [Related]
15. Interaction between autophagy and senescence is required for dihydroartemisinin to alleviate liver fibrosis.
Zhang Z; Yao Z; Zhao S; Shao J; Chen A; Zhang F; Zheng S
Cell Death Dis; 2017 Jun; 8(6):e2886. PubMed ID: 28617435
[TBL] [Abstract][Full Text] [Related]
16. Dihydroartemisinin alleviates hepatic fibrosis through inducing ferroptosis in hepatic stellate cells.
Zhang Z; Wang X; Wang Z; Zhang Z; Cao Y; Wei Z; Shao J; Chen A; Zhang F; Zheng S
Biofactors; 2021 Sep; 47(5):801-818. PubMed ID: 34129254
[TBL] [Abstract][Full Text] [Related]
17. MeCP2 silencing of LncRNA H19 controls hepatic stellate cell proliferation by targeting IGF1R.
Yang JJ; Liu LP; Tao H; Hu W; Shi P; Deng ZY; Li J
Toxicology; 2016 Jun; 359-360():39-46. PubMed ID: 27350269
[TBL] [Abstract][Full Text] [Related]
18. PBI-4050 Reduces Stellate Cell Activation and Liver Fibrosis through Modulation of Intracellular ATP Levels and the Liver Kinase B1/AMP-Activated Protein Kinase/Mammalian Target of Rapamycin Pathway.
Grouix B; Sarra-Bournet F; Leduc M; Simard JC; Hince K; Geerts L; Blais A; Gervais L; Laverdure A; Felton A; Richard J; Ouboudinar J; Gagnon W; Leblond FA; Laurin P; Gagnon L
J Pharmacol Exp Ther; 2018 Oct; 367(1):71-81. PubMed ID: 30093459
[TBL] [Abstract][Full Text] [Related]
19. Liver X receptors balance lipid stores in hepatic stellate cells through Rab18, a retinoid responsive lipid droplet protein.
O'Mahony F; Wroblewski K; O'Byrne SM; Jiang H; Clerkin K; Benhammou J; Blaner WS; Beaven SW
Hepatology; 2015 Aug; 62(2):615-26. PubMed ID: 25482505
[TBL] [Abstract][Full Text] [Related]
20. Lysosome-mediated degradation of a distinct pool of lipid droplets during hepatic stellate cell activation.
Tuohetahuntila M; Molenaar MR; Spee B; Brouwers JF; Wubbolts R; Houweling M; Yan C; Du H; VanderVen BC; Vaandrager AB; Helms JB
J Biol Chem; 2017 Jul; 292(30):12436-12448. PubMed ID: 28615446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
